Andtbacka RH, Ross M, Agarwala SS, et al. A phase II multicentre trial of HF10, oncolytic virus immunotherapy, and ipilimumab combination treatment in patients with stage IIIB-IV unresectable or metastatic melanoma. SMR 2017, abstract SMR04-2.
Three-year Safety of Radium-223 in Patients with mCRPC and Symptomatic Bone Metastases
jul 2017 | Uro-oncologie